Has Rajeev Attam, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,337 in general payments to Rajeev Attam, MD across 44 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rajeev Attam, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rajeev Attam, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rajeev Attam, MD

Gastroenterology · Downey, CANPI 1184694309

Payments from drug & device makers

$2,337in general payments, 2019–2025

Across 44 payments — averaging $53.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$1K
Creo Medical Inc.$532
Covidien LP$211
3-d Matrix, Inc.$143
Cook Medical LLC$134
Olympus America Inc.$25

What the payments were for

Travel & lodging$25811%
Food & beverage$2,07989%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	32	$1,292
Creo Medical Inc.	7	$532
Covidien LP	2	$211
3-d Matrix, Inc.	1	$143
Cook Medical LLC	1	$134
Olympus America Inc.	1	$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,337 in reported general payments places this provider in the 50th percentile of 1,885 gastroenterology providers in California.

See all gastroenterology providers in California →

Medicare billing

Part B allowed, 2024

$4,528

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl	264	$5,891
Mesalamine	11	$4,772
Omeprazole	38	$679
Sucralfate	14	$588
Pantoprazole Sodium	23	$304
Carvedilol	11	$103

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Downey

Peter WinkleCypress$116.7M
Manuchehr DaraniSanta Ana$17.7M
Jatinder PruthiLancaster$4.4M
Long DangWestminster$4.3M
Muhammad SheikhFresno$4.3M
Gregory WienerChula Vista$3.5M
Gil MelmedLos Angeles$3M
Christopher BowlusSacramento$3M
Bennett RothLos Angeles$2.8M
Brigid BolandSan Diego$2.4M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →